SELLAS Life Sciences Group, Inc. (SLS)
8.58
+0.16
(+1.90%)
USD |
NASDAQ |
Nov 09, 16:00
8.565
-0.02
(-0.17%)
After-Hours: 17:42
SELLAS Life Sciences Group Gross Profit (Annual) : 0.00 for Dec. 31, 2025
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| December 31, 2022 | 0.443M |
| December 31, 2021 | 6.127M |
| December 31, 2020 | 1.523M |
| December 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| December 31, 2016 | -0.003M |
| December 31, 2015 | -0.355M |
| Date | Value |
|---|---|
| December 31, 2014 | 7.476M |
| December 31, 2013 | 1.836M |
| December 31, 2012 | -0.049M |
| December 31, 2011 | -0.163M |
| December 31, 2010 | -0.172M |
| December 31, 2009 | 0.00 |
| December 31, 2008 | 0.00 |
| December 31, 2007 | 0.00 |
| December 31, 2006 | 0.00 |
| December 31, 2005 | 0.00 |
| December 31, 2004 | 0.00 |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| AbbVie, Inc. | 42.89B |
| ImmunityBio, Inc. | 97.01M |
| TG Therapeutics, Inc. | 515.57M |
| Capricor Therapeutics, Inc. | -1.890M |
| Relay Therapeutics, Inc. | 11.80M |